length bias; length-time bias
Jump to navigation
Jump to search
Introduction
One of 2 major biases that complicate observational studies including randomized-controlled trials on screening tests.
Length bias occurs as the result of the heterogeniety of a single disease. A disease with more aggressive course is more likely to be diagnosed when symptoms occur rather than with a screening program. A disease with a less aggressive course is more likely to be detected with a screening program. Early detection is obviously associated with improved survival, but this may be due to the greater likelihood of detecting less aggressive disease in screening programs.
More general terms
References
- ↑ Medical Knowledge Self Assessment Program (MKSAP) 11, 17. American College of Physicians, Philadelphia 1998
- ↑ Berry DA. Failure of researchers, reviewers, editors, and the media to understand flaws in cancer screening studies: application to an article in Cancer. Cancer. 2014 Sep 15;120(18):2784-91. PMID: https://www.ncbi.nlm.nih.gov/pubmed/24925345 Free Article